1ST LILLY PRIZE LECTURE UNIVERSITY-OF-DUNDEE, JULY-1976 - FACTORS INFLUENCING ANTIPYRINE ELIMINATION

被引：156

作者：

STEVENSON, IH ^{[1
]}

机构：

[1] UNIV DUNDEE,NINEWELLS HOSP,DEPT PHARMACOL & THERAPEUT,DUNDEE DD1 4HN,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 4卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1977.tb00710.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：261 / 265

页数：5

共 27 条

[1] DRUG-METABOLISM IN NORMAL CHILDREN, LEAD-POISONED CHILDREN, AND NORMAL ADULTS [J].

ALVARES, AP ;

KAPELNER, S ;

SASSA, S ;

KAPPAS, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) :179-183

[2] DRUG-METABOLIZING CAPACITY IN STATES OF DRUG DEPENDENCE AND WITHDRAWAL [J].

BALLINGE.B ;

BROWNING, M ;

STEVENSO.IH .

BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) :638-&

[3] NORPHENAZONE, A NEW METABOLITE OF PHENAZONE IN HUMAN URINE [J].

BATY, JD ;

PRICEEVA.DA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (01) :83-84

[4] INCREASED CLEARANCE OF ANTIPYRINE AND D-PROPRANOLOL AFTER PHENOBARBITAL TREATMENT IN MONKEY - RELATIVE CONTRIBUTIONS OF ENZYME-INDUCTION AND INCREASED HEPATIC BLOOD-FLOW [J].

BRANCH, RA ;

SHAND, DG ;

WILKINSON, GR ;

NIES, AS .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (04) :1101-1107

[5]

BRODIE BB, 1949, J BIOL CHEM, V179, P25

[6]

BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97

[7]

CROOKS J, 1976, Clinical Pharmacokinetics, V1, P280

[8]

CROOKS J, 1973, BRIT J PHARMACOL, V49, pP156

[9]

FORREST JAH, 1974, BMJ-BRIT MED J, V4, P499, DOI 10.1136/bmj.4.5943.499

[10]

GREENBERG IA, 1950, ANTIPYRINE

← 1 2 3 →